such as next-generation algorithms. Others focus less on the research side of things, but instead on applying existing technology to critical real-world problems. Insilico Medicine does both. This Hong Kong-based biotech company has been working toward its mission of using AI for drug discovery ...
Atomic AIis a biotech startup that leverages AI and machine learning to expedite RNA drug development and find cures to ‘untreatable’ illnesses. Backed by notable VC firms such as Greylock, Atomic AI’s platform works to develop RNA tools, medicines, and targeted small molecules through deep ...
首先与Quris-AI合作来扩大他们的药物毒性预测平台，除此以外默克还与BenevolentAI和Exscientia签署了总价值...
公司名称:星亢原(neoX Biotech) 获奖产品/技术/解决方案:基于人工智能和生物物理的创新药物研发 具体描述:星亢原(neoX Biotech)是中国第一家将人工智能(AI)、生物物理以及高通量实验有机结合,进行生物大分子和多特异性分子(如蛋白降解剂)等前沿药物研发的科技公司。针对治疗药物的早期发现,通过深度表征蛋白质-蛋白质相...
Check out this list of the top Biotech companies in San Diego, CA. See company benefits, info, interviews and more at Built In.
Boston, Massachusetts, USA– June 27, 2024 –ArisGlobal, a technology company at the forefront of life sciences and creator of LifeSphere®, today announced one of the world’s largest biotech companies is live on LifeSphere® MultiVigilance and Reporting...
(注:募集金额参考https://www.beauhurst.com/blog/biotech-pharma-companies-uk/) 2.英国“生物&制药”30强公司/逐一分析 2.1 Artios Pharma 2.1.1 融资情况介绍 Artios Pharma总部位于剑桥Babraham研究所,成立于2015年,研究方向为靶向DNA损伤应答(DDR)途径的开创性癌症治疗方法,该公司于2021年入选Business Cloud ...
distribution agreements with partners in Asia-Pacific, Canada—and most recently, Europe (with GC Biotech of The Netherlands, announced in July). S2 is also partnering with the RIKEN Center for Integrative Medical Sciences to evaluate the performance of the system and develop new applications for ...
2018年7月,该公司获得了900万美元的风险投资,并希望在未来几年推出工业规模的商业存储服务。(新浪医药编译/newborn) 文章参考来源: 1、2019:the world's most innovative companies in biotech 2、Fast Company Selects Biotech Companies as Part of Its 2019 List of Innovative Companies...
图2-14 OriBiotech主营业务介绍[27] 2.15 MISSION Therapeutics 2.15.1 融资情况介绍 MISSION Therapeutics,成立于2011年,源自剑桥,药物开发方向为阻滞肿瘤细胞的生长和增殖,尤其是DUB药物的发现与开发。截止2022年8月,该公司已经通过Innovate UK和Michael J. Fox基金会获得了445万英镑资助。另,通过4轮融资获得了9800...